IP Library Granted Patent US 12,251,489
Granted Patent B2
US 12,251,489 · App. 17/309,515 · Granted Mar 18, 2025

Sterilization chemical indicator

Inventors: G. Marco Bommarito (Stillwater, MN); Scott D. Anderson (Lakeland, MN); Ryan W. Clarke (Woodbury, MN); Paul N. Holt (St. Paul, MN); William E. Foltz (Cottage Grove, MN); Timothy J. Nies (Stillwater, MN); Kevin D. Landgrebe (Woodbury, MN)
Assignee: Solventum Intellectual Properties Company
A61L2/28A61L2/07G01N33/525A61L2202/14A61L2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,251,489
App. No.
17/309,515
Granted
Mar 18, 2025
Kind
B2
Abstract

The present disclosure relates generally to chemical indicators. In particular, the chemical indicators are useful for monitoring sterilization processes. The chemical indicator includes a fluid pathway and a chamber comprises a chemical-indicating composition.

Claims (19)

1. A chemical indicator comprising:

a first sheet substantially impermeable to a sterilant;

a second sheet substantially impermeable to the sterilant positioned in an overlapping relationship with respect to the first sheet;

a third sheet disposed in between the first sheet and the second sheet;

a fluid pathway forming an open channel, the open channel defined by the first sheet forming a bottom portion of the fluid pathway, the second sheet forming a top portion of the fluid pathway, and the third sheet forming two side portions of the fluid pathway; a first end having a first opening facing out of the chemical indicator; and a second end having a second opening in fluid communication with a chamber;

and the chamber comprising a chemical composition, wherein the chamber is defined by a cutaway region of the third sheet.

2. A flat-format sterilization process challenge device comprising: a container comprising a chemical indicator, wherein the chemical indicator comprises: a chamber comprising a chemical-indicating composition; a first sheet; a second sheet positioned in an overlapping relationship with respect to the first sheet; a third sheet disposed in between the first sheet and the second sheet, the third sheet including a cutaway region to define a first fluid pathway, a second fluid pathway between ambiance and the chemical indicator, wherein the first fluid pathway is defined by the first sheet, the second sheet, and the third sheet, and wherein the first fluid pathway including a first opening and a second opening; wherein the first opening provides fluid communication with an interior of the container; wherein the second opening of the first fluid pathway is in fluid communication with the chamber, such that the chamber is in fluid communication with the interior of the container only via the first opening of the fluid pathway.

3. The chemical indicator according to claim 1 , wherein the first sheet and the third sheet are combined into a single monolithic layer.

4. The chemical indicator according to claim 1 , wherein the second and third sheets are combined into a single monolithic layer.

5. The chemical indicator according to claim 1 , wherein only one fluid pathway communicates the chamber with ambience.

6. The chemical indicator according to claim 1 , wherein each of the first fluid pathway, and the second fluid pathway, if present, has a length L of no greater than 10 cm.

7. The chemical indicator according to claim 1 , wherein the first opening of the fluid pathway provides fluid communication with an interior of the chamber and has a width W, a height H, and an aspect ratio W/H of width to height of at least 4 (4:1).

8. The chemical indicator according to claim 1 , wherein the chamber is a portion along a length of the fluid pathway.

9. The chemical indicator according to claim 1 , wherein the chamber extends substantially along an entire length of the first fluid pathway or the second fluid pathway, if present, and wherein the chemical indicating composition is present substantially on the entire length of the chamber.

10. The chemical indicator according to claim 1 , further comprising a second fluid pathway positioned to connect the chamber to ambience.

11. The chemical indicator according to claim 1 , wherein the fluid pathway is configured to allow the sterilant to move along the fluid pathway in a plane parallel to the plane defined by the first sheet and the second sheet.

12. The chemical indicator according to claim 1 , further comprising a process challenge device comprising at least a chemical indicator, wherein the chemical indicator is in a container comprising an third fluid pathway that provides fluid communication between ambience and the container.

13. The chemical indicator according to claim 1 , wherein an array of chemical indicators comprises two or more chemical indicators.

14. The chemical indicator according to claim 1 directed to arrays, where the fluid pathway for each of the chemical indicators modulates flow of the sterilant in a manner different from one other.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066443/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2021
From: BOMMARITO, G. MARCO; ANDERSON, SCOTT D.; CLARKE, RYAN W.; HOLT, PAUL N.; FOLTZ, WILLIAM E.; NIES, TIMOTHY J.; LANDGREBE, KEVIN D.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 056424/0054 →
Continuity (2)
Provisional Application 62783764 · Dec 21, 2018
Related Publication 20220054692A1 · Feb 24, 2022
References Cited (28)
US 4138216A · Larsson · 1979 [cited by applicant]
US 4410493A · Joslyn · 1983 [cited by applicant]
US 4579715A · Bruso · 1986 [cited by applicant]
US 5217901A · Dyckman · 1993 [cited by examiner]
US 5872004A · Bolsen · 1999 [cited by applicant]
US 6485979B1 · Kippenhan · 2002 [cited by applicant]
US 6897059B2 · Foltz · 2005 [cited by applicant]
US 7045343B2 · Witcher · 2006 [cited by applicant]
US 7247482B2 · Lemus · 2007 [cited by applicant]
US 7481975B2 · Read · 2009 [cited by applicant]
US 7927866B2 · Justi · 2011 [cited by applicant]
US 9017994B2 · Franciskovich · 2015 [cited by applicant]
US 11065354B2 · Hajime et al. · 2021 [cited by examiner]
US 20030215923A1 · Witcher · 2003 [cited by applicant]
US 20080261296A1 · Justi · 2008 [cited by examiner]
US 20130168327A1 · Clark · 2013 [cited by examiner]
EP 202724A · 1986 [cited by examiner]
EP 0428245 · 1991 [cited by applicant]
EP 2362786 · 2011 [cited by applicant]
JP 2003159649A · 2003 [cited by applicant]
JP 2015512620A · 2015 [cited by applicant]
JP 2018516105A · 2018 [cited by applicant]
WO WO2002087639 · 2002 [cited by applicant]
WO 2013122852A1 · 2013 [cited by applicant]
WO 2016164329A1 · 2016 [cited by applicant]
WO 2018106860A1 · 2018 [cited by applicant]
WO WO2020217093 · 2020 [cited by applicant]
International Search Report for PCT International Application No. PCT/IB2019/061110, mailed on Jun. 25, 2020, 6 pages. [cited by applicant]